Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00274
|
|||||
| Drug Name |
Docosahexaenoic acid
|
|||||
| Synonyms |
(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid; (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid; 6217-54-5; AquaGrow Advantage; CCRIS 7670; CHEMBL367149; Cervonic acid; Doconexent; Doconexento; Doconexentum; Docosahexaenoate; Docosahexaenoic acid; Docosahexaenoic acid (all-Z); Doxonexent; Eicosapentaenoic acid/docosa-hexaenoic acid; Martek DHA HM; Ropufa 60; UNII-ZAD9OKH9JC; ZAD9OKH9JC; all-Z-Docosahexaenoic acid; all-cis-4,7,10,13,16,19-Docosahexaenoic acid; all-cis-DHA; all-cis-docosa-4,7,10,13,16,19-hexaenoic acid; cis-4,7,10,13,16,19-Docosahexaenoic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Alzheimer disease [ICD11: 8A20] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H32O2
|
|||||
| Canonical SMILES |
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O
|
|||||
| InChI |
InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-
|
|||||
| InChIKey |
MBMBGCFOFBJSGT-KUBAVDMBSA-N
|
|||||
| CAS Number |
CAS 6217-54-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 328.5 | Topological Polar Surface Area | 37.3 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 14 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
6.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10299728
, 103445456
, 104046523
, 104086818
, 104179148
, 104634620
, 118048648
, 126524415
, 126621028
, 126655302
, 134350834
, 135028589
, 135651477
, 137003172
, 142339426
, 144205545
, 14924254
, 152101578
, 162180738
, 162227670
, 163659264
, 24893696
, 26754926
, 26754927
, 26754928
, 36888254
, 46391883
, 47515089
, 47515090
, 47885165
, 48184752
, 50110834
, 50110835
, 57404690
, 75281905
, 7850049
, 81063745
, 8144392
, 839059
, 841847
, 85787686
, 8664
, 87568664
, 91695933
, 92165132
, 92298371
, 92309714
, 92719165
, 99300628
, 99302146
|
|||||
| ChEBI ID |
ChEBI:28125
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MFSD2A | Transporter Info | Major facilitator superfamily domain-containing protein 2A | Substrate | [2] | |
| References | ||||||
| 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1051). | |||||
| 2 | Mfsd2a Is a Transporter for the Essential -3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development. J Biol Chem. 2016 May 13;291(20):10501-14. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.